EUVIMEDScopri EUVIMED
Systematische ÜbersichtOpen access · CC BY 4.0

Let food be thy medicine. The interaction between ketogenic diet therapy and anti‐seizure medications: A systematic review

Marisa L Armeno, Eric H Kossoff iD

Epileptic Disorders · 2023

DOI: 10.1002/epd2.20055 ↗

At a glance

Systematische Übersicht in Epileptic Disorders, 2023. Written by Marisa L Armeno and 1 co-authors. Institution: CABA, Hospital Nacional de Pediatria J.P. Garrahan, Buenos Aires, Argentina. Major MEDLINE topics: Epilepsy, Diet, Ketogenic. Cited 22 times so far (Crossref); 52 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Ketogenic diet therapy (KDT) is a nonpharmacological treatment that has been demonstrated to be effective in reducing seizures in patients with drug‐resistant epilepsy. As the majority of patients on KDT are also receiving anti‐seizure medications (ASMs), questions about their combination often arise. KDT is typically implemented as an add‐on, and not a substitute for ASMs. Drug monitoring and specific laboratory studies may be helpful in specific cases of cotherapy. Valproate, topiramate, zonisamide, and lamotrigine may be potentially problematic with KDT, but the evidence for this is not conclusive. ASM reduction is usually attempted after 1 month of KDT if a child is showing seizure reduction (but weaning ASMs does not require seizure freedom). Failure to wean an ASM does not mean KDT has failed and adding a new ASM may be beneficial in those cases after several months of KDT fine‐tuning. The purpose of this review was to discuss the evidence for possible negative (or positive) pharmacodynamic interactions between KDT and ASMs. In addition, practical suggestions for the weaning or adding of ASMs in patients on KDT are provided.

Subjects

MeSH terms (MEDLINE)

EpilepsyDiet, KetogenicChildHumansAnticonvulsantsValproic AcidTopiramateKetone Bodies

Author keywords

anti-seizure medicationsdrug-resistant epilepsyketogenic diet therapyketosis

Substances

AnticonvulsantsValproic AcidTopiramateKetone Bodies

Authors and institutions

  • CABA, Hospital Nacional de Pediatria J.P. Garrahan, Buenos Aires, Argentina.
  • Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

ORCID profiles: Eric H Kossoff

Cite

APA

Armeno, M. L., & Kossoff, E. H. (2023). Let food be thy medicine. The interaction between ketogenic diet therapy and anti‐seizure medications: A systematic review. Epileptic Disorders. https://doi.org/10.1002/epd2.20055

Vancouver

Armeno ML, Kossoff EH. Let food be thy medicine. The interaction between ketogenic diet therapy and anti‐seizure medications: A systematic review. Epileptic Disorders. 2023. doi:10.1002/epd2.20055

BibTeX
@article{Armeno2023,
  author = {Armeno, Marisa L and Kossoff, Eric H},
  title = {Let food be thy medicine. The interaction between ketogenic diet therapy and anti‐seizure medications: A systematic review},
  journal = {Epileptic Disorders},
  year = {2023},
  doi = {10.1002/epd2.20055}
}
Start for free →